Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05098405
Title First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Molecular Partners AG

skin squamous cell carcinoma

head and neck squamous cell carcinoma

prostate cancer

Advanced Solid Tumor

breast cancer

cervical cancer

colorectal cancer

bladder urothelial carcinoma

stomach cancer

endometrial cancer

lung non-small cell carcinoma

pancreatic cancer

malignant mesothelioma

anus cancer

ovarian cancer




Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.